Loading clinical trials...
Loading clinical trials...
A Pilot Study of Adcetris Treatment in Active Diffuse Cutaneous Systemic Sclerosis (Diffuse Scleroderma)
Conditions
Interventions
Brentuximab Vedotin
Locations
1
Canada
Rheumatology Clinic, St. Joseph's Health Care
London, Ontario, Canada
Start Date
May 7, 2019
Primary Completion Date
June 7, 2023
Completion Date
August 28, 2023
Last Updated
October 4, 2023
NCT05270668
NCT04986605
NCT04478994
NCT02161406
NCT00433186
Lead Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions